This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Dafydd Rhys Owen: Innovator in Pyridazine Derivatives
Introduction
Dafydd Rhys Owen is a notable inventor based in Great Britain. He has made significant contributions to the field of pharmaceuticals, particularly through his work on pyridazine derivatives. His innovative approach focuses on developing compounds that have potential therapeutic applications.
Latest Patents
Dafydd Rhys Owen currently holds no patents. However, he has developed a noteworthy invention titled "Pyridazine Derivatives With Autotaxin Activity For Use In Therapy." This invention provides compounds that are useful in treating fibrotic diseases, cancer, and pain. The compounds are characterized by a complex formula that includes various cyclic groups and substituents, showcasing his expertise in medicinal chemistry.
Career Highlights
Dafydd Rhys Owen is associated with Inhibitaxin Limited, where he continues to work on innovative pharmaceutical solutions. His research focuses on creating compounds that can significantly impact the treatment of various diseases. His dedication to advancing medical science is evident in his work.
Collaborations
Dafydd collaborates with Karl Richard Gibson, contributing to the development of new therapeutic agents. Their partnership aims to enhance the efficacy of treatments available for patients suffering from serious health conditions.
Conclusion
Dafydd Rhys Owen is a dedicated inventor whose work on pyridazine derivatives holds promise for future medical therapies. His contributions to the field of pharmaceuticals reflect his commitment to innovation and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile